KBC Group
WGS icon

KBC Group’s GeneDx Holdings WGS Stock Holding History

KBC Group’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-503
Closed -$32K – 1889
2026
Q1 		$32K Hold
503
– – ﹤0.01% 1783
2025
Q4 		$65K Hold
503
– – ﹤0.01% 1536
2025
Q3 		$54K Hold
503
– – ﹤0.01% 1626
2025
Q2 		$46K Sell
503
-417
-45% -$32.7K ﹤0.01% 1632
2025
Q1 		$81K Buy
+920
New +$79.8K ﹤0.01% 1596

Other funds holding WGS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

KBC Group's WGS Position: Q2 2026 in Review

KBC Group sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 503 shares — an estimated $32K sold.

KBC Group first reported a position in WGS in Q1 2025 and held it in 5 quarters. The position peaked at $81K in Q1 2025. 77 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • KBC Group reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • KBC Group sold 503 GeneDx Holdings shares in Q2 2026, an estimated $32K.
  • KBC Group first reported a position in GeneDx Holdings in Q1 2025 and held it in 5 quarters.
  • KBC Group's GeneDx Holdings position peaked at $81K in Q1 2025.
  • 77 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.